UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of May 2026
Commission File Number: 001-41586
MOOLEC SCIENCE SA
(Exact name of Registrant as Specified in Its Charter)
89 Nexus Way, Camana Bay
Grand Cayman KY1-9009
Cayman Islands
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
EXPLANATORY NOTE
The information contained in this Form 6-K and any exhibits hereto
shall be deemed to be incorporated by reference into the Company’s registration statement on Form
S-8 (Registration No. 333-282263).
Moolec Science SA held an Annual General Meeting
of Shareholders
Moolec Science SA (NASDAQ: MLEC), a public limited
liability company incorporated under the laws of the Cayman Islands, with its registered office at 89 Nexus Way, Camana Bay, Grand Cayman
KY1-9009, Cayman Islands (“Moolec,” the “Company,” “we,” “us,” or “our”),
held a virtual annual general meeting of shareholders (the “AGM”), on May 13, 2026, at 9:00 am (Eastern Time).
A total of 1,482,096 ordinary
shares out of 2,080,437 ordinary shares entitled to vote (representing 71.240%) were represented at the meeting. Accordingly, a quorum
was present in accordance with the Company’s articles of association. At or prior to the AGM, the Company’s shareholders voted
on the three proposals set forth below. Each proposal was approved at the AGM by more than a simple majority of the votes cast, in accordance
with applicable law and the Company’s articles of association.
The AGM considered and voted
on the following agenda points:
Resolution 1: Approval of
the Financial Statements
IT IS RESOLVED, AS AN ORDINARY
RESOLUTION THAT the report of the independent auditor on the Company´s consolidated financial statements for the financial year
ended June 30, 2025, and the Company´s consolidated financial statements for the financial year ended June 30, 2025, be approved.
Resolution 2:
Appointment of Directors
IT IS RESOLVED, AS AN
ORDINARY RESOLUTION to re-elect Diego Abelleyra Llodra, as a director of the Company, whose term is expiring at the conclusion of
this AGM, and who being eligible, is standing for re-election as a director of the Company, for a term expiring at the conclusion of
the next-following annual general meeting of the Company (unless re-elected at such annual general meeting) or until such person's
respective successors is duly appointed.
IT IS RESOLVED, AS AN ORDINARY
RESOLUTION to re-elect Oscar Leon Bentancor, as a director of the Company, whose term is expiring at the conclusion of this AGM, and who
being eligible, is standing for re-election as a director of the Company, for a term expiring at the conclusion of the next-following
annual general meeting of the Company (unless re-elected at such annual general meeting) or until such person's respective successors
is duly appointed.
IT IS RESOLVED, AS AN ORDINARY
RESOLUTION to re-elect Romualdo Varela, as a director of the Company, whose term is expiring at the conclusion of this AGM, and who being
eligible, is standing for re-election as a director of the Company, for a term expiring at the conclusion of the next-following annual
general meeting of the Company (unless re-elected at such annual general meeting) or until such person's respective successors is duly
appointed.
IT IS RESOLVED, AS AN ORDINARY
RESOLUTION to re-elect Daniel Core as a director of the Company, whose term is expiring at the conclusion of this AGM, and who being eligible,
is standing for re-election as a director of the Company, for a term expiring at the conclusion of the next-following annual general meeting
of the Company (unless re-elected at such annual general meeting) or until such person's respective successors is duly appointed.
Resolution 3: Appointment
of PwC
IT IS RESOLVED, AS AN ORDINARY
RESOLUTION THAT, the re-appointment of Price Waterhouse & Co. S.R.L. as the independent registered public accounting firm of the Company
for fiscal year ending on June 30, 2026, be approved.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
Moolec Science SA |
| |
(registrant) |
| |
|
|
| Date: May 14, 2026 |
By: |
/s/ Alejandro Antalich |
| |
Name: |
Alejandro Antalich |
| |
Title: |
Chief Executive Officer |
